VivoSim Labs, Inc. operates as a biotechnology firm primarily focused on developing three-dimensional tissue models engineered to accurately replicate key characteristics of human diseases. At the core of their operations is an advanced 3D human tissue platform. This innovative system incorporates their exclusive NovoGen Bioprinters—automated instruments designed to fabricate living 3D tissues from mammalian cells—along with supporting technologies crucial for formulating bio-inks and bioprinting intricate multicellular structures.